-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: Harmony Biosciences Announces Record Q2 2026 Revenue and Shares Initial Clinical Data for Its Orexin-2 Agonist BP-205 Reinforcing Potential Best-in-Class Profile

Dow Jones·08/04/2026 11:30:00

Please log in to view news